Sugi Predict

Sugi Predict / Targets / TARBP2

TARBP2

RISC-loading complex subunit TARBP2 · Q15633 · TARBP2 on Sugi Atlas →

9,818 patent compounds predicted against TARBP2, 5,977 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL2485336 SCHEMBL2485336 0.94 7/20
SCHEMBL1051765 SCHEMBL1051765 0.71 7/20
SCHEMBL1563637 SCHEMBL1563637 0.71 7/20
SCHEMBL2486987 SCHEMBL2486987 0.68 7/20
SCHEMBL369945 SCHEMBL369945 0.60 7/20
SCHEMBL2616840 SCHEMBL2616840 0.58 7/20
SCHEMBL1563764 SCHEMBL1563764 0.58 7/20
SCHEMBL2778345 SCHEMBL2778345 0.70 6/20
SCHEMBL416912 SCHEMBL416912 0.64 6/20
SCHEMBL627988 SCHEMBL627988 0.62 6/20
SCHEMBL2490988 SCHEMBL2490988 0.59 6/20
SCHEMBL892924 SCHEMBL892924 0.56 6/20
SCHEMBL820647 SCHEMBL820647 0.56 6/20
SCHEMBL1302124 SCHEMBL1302124 0.52 6/20
SCHEMBL326844 SCHEMBL326844 0.45 6/20
SCHEMBL2004474 SCHEMBL2004474 0.45 6/20
SCHEMBL2790527 SCHEMBL2790527 0.56 5/20
SCHEMBL768606 SCHEMBL768606 0.50 5/20
SCHEMBL435212 SCHEMBL435212 0.47 5/20
SCHEMBL361590 SCHEMBL361590 0.44 5/20

Clinical trials — most relevant to TARBP2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy EARLY_PHASE1RECRUITING
[18F]ACI-19626 PET in TDP-43 Proteinopathies EARLY_PHASE1RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Biomarkers of Cancer-Associated Myositis nanACTIVE_NOT_RECRUITING
Identification of New FTLD Genes nanUNKNOWN
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
MEHMO Natural History and Biomarkers nanRECRUITING
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization nanCOMPLETED
Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MicroRNAs and Cytokines in Peri-Implantitis Tissue nanUNKNOWN
Gait in Rare Diseases nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction nanCOMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors nanACTIVE_NOT_RECRUITING
Susceptibility Genes in Autism Spectrum Disorders nanCOMPLETED
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy. nanUNKNOWN
Danish Diabetes Birth Registry 2 nanRECRUITING
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a TARBP2 binder may also engage these)

ProteinNameSimilarity
Q3SWU0 — 1.000 Q3SWU0 →
Q0IIG6 — 1.000 Q0IIG6 →
P97473 — 1.000 P97473 →
Q6GPZ1 — 0.994 Q6GPZ1 →
Q5BJ52 — 0.993 Q5BJ52 →
Q4SS66 — 0.992 Q4SS66 →
Q7SXR1 — 0.984 Q7SXR1 →
Q4V8C7 — 0.970 Q4V8C7 →
Q9WTX2 — 0.970 Q9WTX2 →
O75569 — 0.969 O75569 →
Q2HJ92 — 0.966 Q2HJ92 →
A2AWP8 — 0.957 A2AWP8 →
Q9HCE6 — 0.956 Q9HCE6 →
Q5XIS9 — 0.955 Q5XIS9 →
Q9Z272 — 0.954 Q9Z272 →
Q9Y2X7 — 0.954 Q9Y2X7 →
Q5R5M3 — 0.954 Q5R5M3 →
Q29RM4 — 0.954 Q29RM4 →
Q66H91 — 0.954 Q66H91 →
O94888 — 0.953 O94888 →
Q5REY7 — 0.953 Q5REY7 →
Q7ZYA5 — 0.953 Q7ZYA5 →
Q80VL1 — 0.953 Q80VL1 →
Q922P9 — 0.952 Q922P9 →
Q66T02 — 0.952 Q66T02 →
Q99MU3 — 0.951 Q99MU3 →
P97616 — 0.950 P97616 →
Q5JSP0 — 0.950 Q5JSP0 →
Q91836 — 0.950 Q91836 →
Q68FF6 — 0.950 Q68FF6 →